The unknown biology of the unknown primary tumour: a literature review.
The unknown primary tumour (UPT) is an intriguing clinical phenomenon found in approximately 5% of all newly diagnosed patients with cancer. It is unclear whether UPT forms a distinct biological entity with specific genetic and phenotypic characteristics, or whether it is merely a clinical presentation of metastases in patients in whom the primary tumour cannot be detected and does not result in any visible clinical signs. Understanding the basic biology of UPT may shed light on this issue and, moreover, may have a direct impact on clinical care. A review of the literature revealed only a limited number of publications describing the genetic and phenotypic features of UPT, most of which focus only on the potential of these markers to predict prognosis. The question as to whether the biology of UPT is different from tumours of known primaries therefore remains unanswered. Further insight into the molecular mechanisms underlying the oncogenesis of UPT, e.g. by applying newly available DNA and gene profiling microarray techniques, will be necessary to understand its specific biology and to develop more effective treatments.
van de Wouw
A J
AJ
Department of Internal Medicine, Slingeland Hospital Doetinchem, Doetinchem, The Netherlands. y.van.de.wouw@slingeland.nl
Jansen
R L H
RL
Speel
E J M
EJ
Hillen
H F P
HF
D000782:Aneuploidy; D002869:Chromosome Aberrations; D020869:Gene Expression Profiling; D016147:Genes, Tumor Suppressor; D006801:Humans; D009362:Neoplasm Metastasis / Q000503:physiopathology*; D009382:Neoplasms, Unknown Primary / Q000235:genetics* / Q000503:physiopathology*; D009389:Neovascularization, Pathologic; D009857:Oncogenes; D010641:Phenotype; D011379:Prognosis